Arginine Drives Metabolic Changes in Liver Cancer Cells

Scientists at the University of Basel have uncovered a key driver of metabolic changes in liver cancer cells. Their research reveals that high levels of the amino acid arginine promote metabolic reprogramming, enabling tumor growth. This discovery could open new avenues for the treatment of liver cancer, one of the most lethal forms of cancer.

Liver cancer is a deadly disease often associated with factors like obesity, excessive alcohol consumption, and hepatitis C infection. Early diagnosis and effective therapeutic strategies are crucial for improving outcomes in liver cancer patients.

Traditionally, cancer has been viewed as a disorder of uncontrolled cell proliferation. However, emerging evidence suggests that cancer is fundamentally a metabolic disease. Cancer cells rewire their metabolism to fuel uncontrolled growth. This metabolic shift plays a pivotal role in the development of tumors.

In their study published in Cell, the researchers found elevated levels of arginine in liver tumor samples from both mice and human patients. Interestingly, cancer cells produce less or none of this amino acid but accumulate high levels by increasing its uptake and suppressing its consumption.

High concentrations of arginine bind to a specific factor that triggers metabolic reprogramming, promoting tumor growth by regulating the expression of metabolic genes. This leads to tumor cells reverting to an undifferentiated embryonic cell state, where they can divide indefinitely. Additionally, tumor cells benefit from increased arginine uptake by escaping the immune system, as immune cells rely on arginine to function properly.

The implications for cancer therapy are significant. Instead of depleting arginine, the scientists propose targeting the specific arginine-binding factor to prevent metabolic reprogramming. This approach could avoid unwanted side effects, such as harming immune cells that require arginine. Furthermore, increased arginine levels may serve as biomarkers for early cancer detection, which is crucial for successful treatment and patient survival.